| Property | Value |
|---|
|
?:abstract
|
-
Mental health clinicians worldwide have been expressing concerns regarding the broad psychological effects of the COVID-19 pandemic. Nonetheless, only a few studies have thus far evaluated the degree of fear of COVID-19, partially due to the lack of validated measures. In this study we evaluated the psychometric properties of the Hebrew version of the Fear of COVID-19 scale (FCV-19S), recently developed to assess different aspects of the fear of the pandemic, in a normative population of participants in Israel. Participants (n = 639) were asked to complete the FCV-19S scale, as well as to report anxiety, depression, and stress levels using validated scales. The results a unidimensional factor structure of the FCV-19S which explained 53.71% of the variance. When forcing a two-factor structure model, the analysis revealed two factors pertaining to emotional fear reactions and symptomatic expressions of fear. Gender, sociodemographic status, chronic illness, being in an at-risk group, and having a family member dying of COVID-19 were positively associated with fear of COVID-19. The measure was associated with anxiety, stress and depression. These results suggest that the FCV-19S has good psychometric properties, and can be utilized in studies assessing the effects of the pandemic on the population\'s mental health.
|
|
?:creator
|
|
|
?:doi
|
-
10.1016/j.psychres.2020.113100
|
|
?:doi
|
|
|
?:journal
|
-
Psychiatry_Res
-
Psychiatry_research
|
|
?:license
|
|
|
?:pdf_json_files
|
-
document_parses/pdf_json/69c9f952ff0038aaaf3e619fdd982f9ad95b6bd1.json
|
|
?:pmc_json_files
|
-
document_parses/pmc_json/PMC7227556.xml.json
|
|
?:pmcid
|
|
|
?:pmid
|
|
|
?:pmid
|
-
32425276.0
-
32540750
-
33250092.0
|
|
?:publication_isRelatedTo_Disease
|
|
|
?:sha_id
|
|
|
?:source
|
-
Elsevier; Medline; PMC
-
Medline
|
|
?:title
|
-
Fear of COVID-19 scale: Psychometric characteristics, reliability and validity in the Israeli population
-
Fear of COVID-19 scale: Psychometric characteristics, reliability and validity in the Israeli population.
|
|
?:type
|
|
|
?:year
|
|
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}